Experience in action

From FY2022 to FY2025, gross margin rose from 7.8% to 28.9%. Operating result moved from a PKR 580M loss to a PKR 180M profit: a PKR 760M swing. Equity rose from PKR 203M to PKR 581M. The going-concern warning was removed.

In early 2023, Farhan Bedar Malik undertook a combined consulting and interim management mandate as Executive Advisor to the sponsors, with executive authority. The results belong to the whole company: its management and staff, who ran the programme, and its sponsors, who funded the recovery.

Operating profit is gross profit less administrative and selling and distribution expenses. It excludes the gain on land sales. FY2022 uses the comparative in the FY2023 audited report. Sources: Mitchell’s audited annual reports FY2022–FY2025.

Consumer health · Pakistan · 2009

Asked for profit ahead of sales, we reorganised the field into four channels and gave up 80 positions. Operating income was 39% above target. Productivity per representative was PKR 16M against PKR 13M for leading multinationals.

A partner achievement from a previous executive leadership role.

Consumer health · Pakistan · 2006

Doctors covered rose from 12,500 to 21,000+. We split medical promotion from trade marketing, redrew the field and moved brands it could not promote to an outsourced distributor model. Volume in the outsourced brands rose 20%.

A partner achievement from a previous executive leadership role.

Consumer health · Gulf · 2015

Large chains held over eight months of stock, helped by discounts of up to 38%. We agreed a plan to sell only what each chain ran out of and cap discounts at 30%. Chain stock normalised in about six months.

A partner achievement from a previous executive leadership role.